Stocklytics Platform
Asset logo for symbol NRC
National Research
NRC51
$19.46arrow_drop_down2.45%-$0.48
Asset logo for symbol NRC
NRC51

$19.46

arrow_drop_down2.45%

Performance History

Chart placeholder
Key Stats
Open$19.85
Prev. Close$19.97
EPS1.19
Next Earnings DateJan 7, 2025
LOWHIGH
Day Range19.23
20.08
52 Week Range19.28
45.49
Ratios
EPS1.19

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About National Research (NRC)

National Research Corp (NRC) is a leading provider of performance measurement solutions for the healthcare industry. With a strong market presence and a track record of excellence, NRC is a trusted partner for healthcare organizations seeking to improve patient experiences and outcomes. NRC's comprehensive suite of products and services enables healthcare providers to collect, analyze, and benchmark data on patient satisfaction, quality of care, and other key performance indicators. By leveraging NRC's insights, healthcare organizations can identify areas for improvement, implement evidence-based practices, and drive positive change.
NRC's stock price history reflects the company's solid performance and growth potential. Over the past several years, NRC's stock price has steadily increased, demonstrating investor confidence in the company's ability to deliver results. This positive trend is supported by NRC's strong financials, including a healthy market cap and a favorable PEG ratio. The company's solid financial position, coupled with its leadership in the healthcare industry, positions NRC well for future growth and success.
Sector
Healthcare
Industry
Health Information Services
CEO
Mr. Michael D. Hays
Headquarters
Lincoln
Employees
491
Exchange
NASDAQ
add National Research to watchlist

Keep an eye on National Research

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is National Research's (NRC) price per share?

The current price per share for National Research (NRC) is $19.46. The stock has seen a price change of -$0.49 recently, indicating a -2.45% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for National Research (NRC)?

For National Research (NRC), the 52-week high is $45.49, which is 133.7% from the current price. The 52-week low is $19.28, the current price is 0.96% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is National Research (NRC) a growth stock?

National Research (NRC) has shown an average price growth of 0.41% over the past three years. It has received a score of 39 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying National Research as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is National Research (NRC) stock price performance year to date (YTD)?

As of the latest data, National Research (NRC) has a year-to-date price change of -52.75%. Over the past month, the stock has experienced a price change of -12.2%. Over the last three months, the change has been -15.19%. Over the past six months, the figure is -46.32%. Looking at a longer horizon, the five-year price change stands at -66.66%.
help

Is National Research (NRC) a profitable company?

National Research (NRC) has a net income of $30.96M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 58.33% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 25.31% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $148.58M, although specific revenue growth data is currently not available. The gross profit is $86.67M. Operating income is noted at $40.09M. Furthermore, the EBITDA is $45.56M.
help

What is the market capitalization of National Research (NRC)?

National Research (NRC) has a market capitalization of $484.11M. The average daily trading volume is 19.54, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media